Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus influenzae Type b (Hib) Vaccination Series. (Q51529660)
Jump to navigation
Jump to search
scientific article published on 29 April 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus influenzae Type b (Hib) Vaccination Series. |
scientific article published on 29 April 2016 |
Statements
Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus influenzae Type b (Hib) Vaccination Series. (English)
1 reference
Haemophilus influenzae
1 reference
Elizabeth C Briere
1 reference
29 April 2016
1 reference
65
1 reference
16
1 reference
418-419
1 reference